Vimarsana
Biggest News Aggregation in the World

Page 2 - Treatment Developments News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Treatment Developments. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Treatment Developments Today - Breaking & Trending Today

Efficacy and Safety of Oral SERDs and Other Endocrine Therapies in ER+/HER2- Metastatic Breast Cancer - Vimarsana News

Efficacy and Safety of Oral SERDs and Other Endocrine Therapies in ER+/HER2- Metastatic Breast Cancer

Published: January 4, 2024

Experts explore the efficacy and safety profiles of elacestrant, an oral Selective Estrogen Receptor Degrader (SERD), and other options for endocrine therapy. The panelists also discuss clinical trial insights, progression-free survival rates, and tolerability, highlighting outcomes and advantages in metastatic breast cancer treatment.

Source: ajmc.com
Related Topics:
Rena CallahanGregory VidalWilliam GradisharMabel MardonesPeer ExchangeOral SerdMetastatic Breast CancerTherapeutic AdvancesPanel DiscussionHer PositiveHer2 NegativeSelective Estrogen Receptor DegraderEndocrine TherapyTargeted TherapyTreatment DevelopmentsMedical OncologyBreast OncologySafety ProfileClinical TrialTreatment ComparisonEsr1 Mutation
Evolution of Endocrine Therapies in ER+/HER2- Metastatic Breast Cancer - Vimarsana News

Evolution of Endocrine Therapies in ER+/HER2- Metastatic Breast Cancer

Published: December 21, 2023

Experts discuss evolving strategies in ER+/HER2- metastatic breast cancer treatment, combining endocrine and targeted therapies, and leveraging specific mutations for optimal patient outcomes.

Source: ajmc.com
Related Topics:
Breast CancerEndocrine TherapiesOral SerdMetastatic Breast CancerTherapeutic AdvancesPanel DiscussionHer PositiveHer2 NegativeSelective Estrogen Receptor DegraderEndocrine TherapyTargeted TherapyTreatment DevelopmentsMedical OncologyBreast Oncology